Detalles de la búsqueda
1.
Evidence-Based Study Design for Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia.
J Infect Dis
; 219(10): 1536-1544, 2019 04 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-30649434
2.
Efficacy and Safety of Intravenous-to-oral Lefamulin, a Pleuromutilin Antibiotic, for the Treatment of Community-acquired Bacterial Pneumonia: The Phase III Lefamulin Evaluation Against Pneumonia (LEAP 1) Trial.
Clin Infect Dis
; 69(11): 1856-1867, 2019 11 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-30722059
3.
The Infectious Diseases Society of America's 10 × '20 Initiative (10 New Systemic Antibacterial Agents US Food and Drug Administration Approved by 2020): Is 20 × '20 a Possibility?
Clin Infect Dis
; 69(1): 1-11, 2019 06 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-30715222
4.
Elaboration of Consensus Clinical Endpoints to Evaluate Antimicrobial Treatment Efficacy in Future Hospital-acquired/Ventilator-associated Bacterial Pneumonia Clinical Trials.
Clin Infect Dis
; 69(11): 1912-1918, 2019 11 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-30722013
5.
Clostridium difficile Infection-Daily Symptoms (CDI-DaySyms™) questionnaire: psychometric characteristics and responder thresholds.
Health Qual Life Outcomes
; 17(1): 77, 2019 May 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31053093
6.
Evolution and current status of United States Food and Drug Administration and European Medicines Agency regulatory guidance for studies of nosocomial pneumonia.
Curr Opin Crit Care
; 24(5): 379-384, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-30156568
7.
The CDI-DaySyms: Content Development of a New Patient-Reported Outcome Questionnaire for Symptoms of Clostridium difficile Infection.
Value Health
; 21(4): 441-448, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29680101
8.
Progress in the Fight Against Multidrug-Resistant Bacteria 2005-2016: Modern Noninferiority Trial Designs Enable Antibiotic Development in Advance of Epidemic Bacterial Resistance.
Clin Infect Dis
; 65(1): 141-146, 2017 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29017263
9.
Once-weekly dalbavancin versus daily conventional therapy for skin infection.
N Engl J Med
; 370(23): 2169-79, 2014 Jun 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-24897082
10.
Plazomicin for Infections Caused by Carbapenem-Resistant Enterobacteriaceae.
N Engl J Med
; 380(8): 791-793, 2019 02 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-30786196
11.
Understanding Early and Late Endpoints in Registrational Trials of Community-acquired Bacterial Pneumonia.
Clin Infect Dis
; 73(9): e2613-e2615, 2021 11 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-32584958
12.
Developing Outcomes Assessments as Endpoints for Registrational Clinical Trials of Antibacterial Drugs: 2015 Update From the Biomarkers Consortium of the Foundation for the National Institutes of Health.
Clin Infect Dis
; 62(5): 603-7, 2016 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26668337
13.
In Vitro Activity of Lefamulin Tested against Streptococcus pneumoniae with Defined Serotypes, Including Multidrug-Resistant Isolates Causing Lower Respiratory Tract Infections in the United States.
Antimicrob Agents Chemother
; 60(7): 4407-11, 2016 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-27161634
14.
Widening the Overton Window-While Avoiding Defenestration.
Clin Infect Dis
; 70(11): 2442-2443, 2020 05 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-31605475
15.
Erratum to: Efficacy and Safety of Intravenous-to-oral Lefamulin, a Pleuromutilin Antibiotic, for the Treatment of Community-acquired Bacterial Pneumonia: The Phase III Lefamulin Evaluation Against Pneumonia (LEAP 1) Trial.
Clin Infect Dis
; 70(11): 2459, 2020 05 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-31626688
16.
Multicenter, Double-Blind, Randomized, Phase 2 Study Evaluating the Novel Antibiotic Cadazolid in Patients with Clostridium difficile Infection.
Antimicrob Agents Chemother
; 59(10): 6266-73, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-26248357
17.
10 x '20 Progress--development of new drugs active against gram-negative bacilli: an update from the Infectious Diseases Society of America.
Clin Infect Dis
; 56(12): 1685-94, 2013 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-23599308
18.
Prospective study of the Wilson severity-of-illness scoring system for complicated skin and skin structure infections.
Antimicrob Agents Chemother
; 57(1): 647-50, 2013 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-23129046
19.
The Fight Against Multidrug-Resistant Bacteria.
Ann Intern Med
; 166(1): 78-79, 2017 01 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-28030674
20.
The Early Clinical Response Endpoint: Great Timing by the Food and Drug Administration?
Clin Infect Dis
; 64(2): 218-220, 2017 01 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-28003217